Network pharmacology and in vitro studies reveal the pharmacological effects and molecular mechanisms of Shenzhi Jiannao prescription against vascular dementia
Abstract Background Shenzhi Jiannao (SZJN) prescription is a type of herbal formula adopted in the management of cognitive impairment and related disorders. However, its effects and related regulatory mechanisms on vascular dementia (VD) are elusive. Herein, network pharmacology prediction was emplo...
Main Authors: | Danfeng Tian, Qiang Gao, Ze Chang, Jingfeng Lin, Dayong Ma, Zhenyun Han |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-02-01
|
Series: | BMC Complementary Medicine and Therapies |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12906-021-03465-1 |
Similar Items
-
Shenzhi Jiannao formula ameliorates vascular dementia in vivo and in vitro by inhibition glutamate neurotoxicity via promoting clathrin-mediated endocytosis
by: Danfeng Tian, et al.
Published: (2021-07-01) -
Molecular mechanism of Epimedium in the treatment of vascular dementia based on network pharmacology and molecular docking
by: Chenchen Xie, et al.
Published: (2022-08-01) -
Mechanism of Astragalus membranaceus in treatment for vascular dementia based on network pharmacology and molecular docking
by: XIONG Rui, et al.
Published: (2023-05-01) -
Network pharmacology and the experimental findings of Bushenhuoxue formula for improving hippocampal neuron injury in vascular demented rats
by: Shan Luo, et al.
Published: (2021-12-01) -
Efficacy of acupuncture and pharmacological therapies for vascular cognitive impairment with no dementia: a network meta-analysis
by: Ruiyu Li, et al.
Published: (2023-06-01)